Intellectual Properties
The mission of Nexpharm Korea for the next generation is human
Nexpharm Korea has a strategy to focus on patent acquisition (original technology) of natural substances in relation to the development of natural medicines. It helps Nexpharm Korea have a monopolistic position in connection with formulation technology, manufacturing process technology and development of analytical methods which increases the success probability of clinical studies.
Intellectual Properties status
- A pharmaceutical composition for the treatment or prophylaxis of metabolic syndrome containing TRAP80 modulator
as an active ingredient (Patent No. 10-1341200) - A pharmaceutical composition for treating or preventing fatty liver comprising an extract of rosemary extract as an
active ingredient (Patent No. 10-1309967) - A composition for a health functional food supplement for preventing or treating hyperlipidemia containing Amomi
Tsao-ko extract as an active ingredient (Patent no. 10-2013-0028281) - A composition for a health functional food supplement for the prevention or treatment of osteoarthritis containing an
Amomi Tsao-ko extract as an active ingredient (Patent No. 10-2013-0028282) - A pharmaceutical composition for the prevention or treatment of inflammatory diseases comprising an en-trans-low-
caffeo-o-thyramine compound extracted from tribulus terrestris as an active ingredient (Patent No. 10-2013-0064204) - A pharmaceutical composition for preventing or treating an inflammatory disease comprising an effective amount of
a dihydrodiciconyl alcohol extracted from tribulus terrestris as an active ingredient (Patent No. 10-2013-0064205) - Development of anti-obesity composition containing Saringosterol (Patent No. 1601843)
- Development of a composition for inhibiting angiogenesis containing mulberry extract as an active ingredient
(Patent No. 10-2013-0144317) - A compound extracted Amomi Tsao-ko and its usage for anti-inflammation (Patent No. 10-2014-0195913)